annual EBITDA:
-$92.74M+$50.42M(+35.22%)Summary
- As of today (May 29, 2025), ANAB annual EBITDA is -$92.74 million, with the most recent change of +$50.42 million (+35.22%) on December 31, 2024.
- During the last 3 years, ANAB annual EBITDA has fallen by -$38.49 million (-70.94%).
- ANAB annual EBITDA is now -1911.05% below its all-time high of $5.12 million, reached on December 31, 2014.
Performance
ANAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$20.62M-$16.83M(-444.73%)Summary
- As of today (May 29, 2025), ANAB quarterly EBITDA is -$20.62 million, with the most recent change of -$16.83 million (-444.73%) on March 1, 2025.
- Over the past year, ANAB quarterly EBITDA has increased by +$16.40 million (+44.30%).
- ANAB quarterly EBITDA is now -154.38% below its all-time high of $37.92 million, reached on December 31, 2020.
Performance
ANAB quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$76.35M+$16.40M(+17.68%)Summary
- As of today (May 29, 2025), ANAB TTM EBITDA is -$76.35 million, with the most recent change of +$16.40 million (+17.68%) on March 1, 2025.
- Over the past year, ANAB TTM EBITDA has increased by +$64.50 million (+45.80%).
- ANAB TTM EBITDA is now -631.56% below its all-time high of $14.36 million, reached on September 30, 2021.
Performance
ANAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANAB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.2% | +44.3% | +45.8% |
| 3 y3 years | -70.9% | +33.1% | -13.7% |
| 5 y5 years | +2.4% | -103.9% | +8.6% |
ANAB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.9% | +35.2% | -444.7% | +47.6% | -13.7% | +46.7% |
| 5 y | 5-year | -406.4% | +35.2% | -154.4% | +47.6% | -631.6% | +46.7% |
| alltime | all time | -1911.0% | +35.2% | -154.4% | +47.6% | -631.6% | +46.7% |
ANAB EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$20.62M(+444.7%) | -$76.35M(-17.7%) |
| Dec 2024 | -$92.74M(-35.2%) | -$3.79M(-77.5%) | -$92.74M(-26.2%) |
| Sep 2024 | - | -$16.84M(-52.0%) | -$125.61M(-10.9%) |
| Jun 2024 | - | -$35.10M(-5.2%) | -$141.06M(+0.1%) |
| Mar 2024 | - | -$37.01M(+1.0%) | -$140.85M(-1.6%) |
| Dec 2023 | -$143.16M(+36.0%) | -$36.65M(+13.5%) | -$143.16M(+11.8%) |
| Sep 2023 | - | -$32.28M(-7.5%) | -$128.04M(+4.5%) |
| Jun 2023 | - | -$34.90M(-11.3%) | -$122.54M(+7.7%) |
| Mar 2023 | - | -$39.33M(+82.6%) | -$113.75M(+8.1%) |
| Dec 2022 | -$105.26M(+94.0%) | -$21.53M(-19.6%) | -$105.26M(-8.0%) |
| Sep 2022 | - | -$26.78M(+2.6%) | -$114.43M(+22.2%) |
| Jun 2022 | - | -$26.11M(-15.3%) | -$93.64M(+39.4%) |
| Mar 2022 | - | -$30.83M(+0.4%) | -$67.17M(+23.8%) |
| Dec 2021 | -$54.26M(+196.3%) | -$30.70M(+412.0%) | -$54.26M(-477.7%) |
| Sep 2021 | - | -$6.00M(-1784.6%) | $14.36M(-494.5%) |
| Jun 2021 | - | $356.00K(-102.0%) | -$3.64M(-86.1%) |
| Mar 2021 | - | -$17.91M(-147.2%) | -$26.11M(+42.6%) |
| Dec 2020 | -$18.31M(-80.7%) | $37.92M(-258.0%) | -$18.31M(-75.7%) |
| Sep 2020 | - | -$24.00M(+8.5%) | -$75.28M(-8.2%) |
| Jun 2020 | - | -$22.12M(+118.7%) | -$81.99M(-1.8%) |
| Mar 2020 | - | -$10.11M(-46.9%) | -$83.49M(-12.2%) |
| Dec 2019 | -$95.04M | -$19.05M(-38.0%) | -$95.04M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$30.71M(+30.0%) | -$92.70M(+19.7%) |
| Jun 2019 | - | -$23.62M(+9.0%) | -$77.46M(+15.7%) |
| Mar 2019 | - | -$21.66M(+29.6%) | -$66.96M(+11.8%) |
| Dec 2018 | -$59.88M(+113.0%) | -$16.71M(+8.1%) | -$59.88M(+20.9%) |
| Sep 2018 | - | -$15.47M(+17.9%) | -$49.52M(+16.1%) |
| Jun 2018 | - | -$13.12M(-10.0%) | -$42.65M(+34.4%) |
| Mar 2018 | - | -$14.58M(+129.3%) | -$31.73M(+12.9%) |
| Dec 2017 | -$28.11M(+687.9%) | -$6.36M(-26.0%) | -$28.11M(+7.4%) |
| Sep 2017 | - | -$8.59M(+291.6%) | -$26.16M(+41.3%) |
| Jun 2017 | - | -$2.19M(-80.0%) | -$18.51M(+34.0%) |
| Mar 2017 | - | -$10.97M(+148.8%) | -$13.82M(+287.3%) |
| Dec 2016 | -$3.57M(-21.3%) | -$4.41M(+368.5%) | -$3.57M(+48.2%) |
| Sep 2016 | - | -$941.00K(-137.7%) | -$2.41M(-10.7%) |
| Jun 2016 | - | $2.50M(-448.9%) | -$2.69M(-46.8%) |
| Mar 2016 | - | -$716.00K(-78.0%) | -$5.06M(+11.7%) |
| Dec 2015 | -$4.53M(-188.5%) | -$3.25M(+164.5%) | -$4.53M(+550.2%) |
| Sep 2015 | - | -$1.23M(-1030.3%) | -$697.00K(-117.1%) |
| Jun 2015 | - | $132.00K(-170.2%) | $4.07M(+3.4%) |
| Mar 2015 | - | -$188.00K(-132.0%) | $3.94M(-4.6%) |
| Dec 2014 | $5.12M(-225.5%) | $587.00K(-83.4%) | $4.12M(+16.6%) |
| Sep 2014 | - | $3.54M | $3.54M |
| Dec 2013 | -$4.08M | - | - |
FAQ
- What is AnaptysBio annual EBITDA?
- What is the all time high annual EBITDA for AnaptysBio?
- What is AnaptysBio annual EBITDA year-on-year change?
- What is AnaptysBio quarterly EBITDA?
- What is the all time high quarterly EBITDA for AnaptysBio?
- What is AnaptysBio quarterly EBITDA year-on-year change?
- What is AnaptysBio TTM EBITDA?
- What is the all time high TTM EBITDA for AnaptysBio?
- What is AnaptysBio TTM EBITDA year-on-year change?
What is AnaptysBio annual EBITDA?
The current annual EBITDA of ANAB is -$92.74M
What is the all time high annual EBITDA for AnaptysBio?
AnaptysBio all-time high annual EBITDA is $5.12M
What is AnaptysBio annual EBITDA year-on-year change?
Over the past year, ANAB annual EBITDA has changed by +$50.42M (+35.22%)
What is AnaptysBio quarterly EBITDA?
The current quarterly EBITDA of ANAB is -$20.62M
What is the all time high quarterly EBITDA for AnaptysBio?
AnaptysBio all-time high quarterly EBITDA is $37.92M
What is AnaptysBio quarterly EBITDA year-on-year change?
Over the past year, ANAB quarterly EBITDA has changed by +$16.40M (+44.30%)
What is AnaptysBio TTM EBITDA?
The current TTM EBITDA of ANAB is -$76.35M
What is the all time high TTM EBITDA for AnaptysBio?
AnaptysBio all-time high TTM EBITDA is $14.36M
What is AnaptysBio TTM EBITDA year-on-year change?
Over the past year, ANAB TTM EBITDA has changed by +$64.50M (+45.80%)